Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | 0.00% | +6.67% | +63.27% |
May. 22 | Optimi Health to Be Sole Supplier of Psilocybin for ATMA Journey Centers Phase II Trial | MT |
May. 14 | Optimi Health Receives Certificate of Analysis for Mdma 40Mg and 60Mg Gmp Capsules | CI |
Sales 2022 | 0.08 0.11 | Sales 2023 | 0.18 0.25 | Capitalization | 16.1M 22.01M |
---|---|---|---|---|---|
Net income 2022 | -7M -9.57M | Net income 2023 | -5M -6.84M | EV / Sales 2022 | 289,422,204 x |
Net cash position 2022 | 1.73M 2.37M | Net Debt 2023 | 362K 496K | EV / Sales 2023 | 90,920,762 x |
P/E ratio 2022 |
-3.29
x | P/E ratio 2023 |
-3.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.73% |
1 week | +6.67% | ||
Current month | +25.00% | ||
1 month | +17.65% | ||
3 months | +37.93% | ||
6 months | +116.22% | ||
Current year | +63.27% |
Managers | Title | Age | Since |
---|---|---|---|
Dane Stevens
FOU | Founder | 34 | 20-05-26 |
William Ciprick
CEO | Chief Executive Officer | 56 | 21-09-06 |
Jacob Safarik
DFI | Director of Finance/CFO | 36 | 20-07-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 45 | 20-10-06 | |
John Wilson
FOU | Founder | 34 | 20-05-26 |
Bryan Safarik
COO | Chief Operating Officer | 39 | 20-07-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.4 | -6.98% | 103,904 |
24-05-27 | 0.43 | -2.27% | 105,097 |
24-05-24 | 0.44 | +11.39% | 226,355 |
24-05-23 | 0.395 | +3.95% | 153,785 |
24-05-22 | 0.38 | +1.33% | 22,205 |
Delayed Quote Canadian Securities Exchange, May 28, 2024 at 03:43 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+63.27% | 26.56M | |
-.--% | 843M | |
+3.15% | 694M | |
+31.19% | 478M | |
+21.64% | 246M | |
0.00% | 130M | |
+113.04% | 59.36M |
- Stock Market
- Equities
- OPTI Stock